Mr. Leung is a partner specializing in corporate finance for publicly traded companies, mergers and acquisitions transactions and international transactions. Mr. Leung is the director of the Asian Practice Group at Richardson & Patel and specializes in representing Asian companies that are raising capital in the US in transactions such as initial public offerings, reverse merger with PIPE offerings and private equity investments. Mr. Leung represents numerous Chinese companies that are public in the US and have taken many such companies public in the US through reverse mergers from finding funding, underwriting or suitable public shell companies to structuring, negotiating and closing the reverse merger to working through all regulatory compliance issues (including registration statements, Exchange Act compliance and Sarbanes-Oxley compliance) to NASDAQ quotation or AMEX listing to financing and mergers & acquisition transactions. In addition, Mr. Leung has handled Asian SPACs, Joint Ventures and other cross border transactions. Mr. Leung is a frequent speaker on the topic of cross border transactions, especially with Chinese companies. Prior to joining Richardson & Patel LLP, Mr. Leung was associated with the international law firm of Paul Hastings Janofsky & Walker LLP.

Larry Liu is specialized in FDI, M&A, overseas listing (including RTO in the US capital market), asset-backed-securitization, project financing and so on. He provides legal services to many renowned companies from both home and overseas. Mr. Liu has provided the first class legal service in many well known projects, such as the asset-backed-securitization project of China Construction Bank, which is the first banking asset securitization project in China, the private placement of Bain Capital in CTV, the joint venture finance company by Credit Suisse and China Poly Corporation, the merger of Daye Steel (an A share listing company), the US and UK listing of Bodisen, RTO of Wuhan Blower, RTO of China Zhongran Gas and so on. Mr. Liu joined Global Law Office as a partner in 2006. Prior to joining Global, Mr. Liu worked with Jingtian & Gongcheng. Before practicing law, Mr. Liu was a senior project manager at the Investment Banking Headquarter of Haitong Securities Co., Ltd.

Mr. Bevilacqua has broad experience in public offerings and private placements of securities, Exchange Act compliance, angel and venture capital financings, other areas of equity and debt financing and mergers, acquisitions and other business combinations, including "roll up" transactions and "reverse acquisition" transactions. In addition to working with NYSE and NASDAQ listed companies, Mr. Bevilacqua has several years of experience working with microcap and nanocap public companies whose securities are quoted on the over-the-counter Bulletin Board, and he understands the special needs of these companies. He also represents companies with international operations, including companies based in the People's Republic of China and Taiwan, Republic of China, and spends a portion of his time working out of the Firm's Shanghai office. Mr. Bevilacqua has significant experience advising life sciences companies including vaccine and other pharmaceutical companies, medical device companies and medical products and medical disposables manufacturers. He also advises emerging technology driven companies on licensing and development transactions, joint ventures, technology-transfers and related intellectual property matters.